"A major emphasis at National Jewish Health is the pediatric program, National Jewish Health for Kids, designed for children and adolescents with allergic, pulmonary and immune system disorders. National Jewish Health for Kids is a program of care from America's best pediatric specialists. National Jewish Health for Kids is unique, comprehensive, effective and available only at National Jewish Health, the leading respiratory hospital in the nation. With National Jewish Health for Kids, we have created an environment in response to the demand from parents and patients for treatment of asthma, atopic dermatitis, food allergies, rhinitis, immune problems and recurrent infections—all diseases that are increasing throughout the country."

During the past decade, National Jewish Health: Division of Pediatric Allergy and Clinical Immunology conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Jewish Health: Division of Pediatric Allergy and Clinical Immunology" #1 collaborator was "Atopic Dermatitis Research Network" with 2 trials as a collaborator, "Rho Federal Systems Division, Inc." with 2 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Novartis Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "National Jewish Health: Division of Pediatric Allergy and Clinical Immunology" are "Atopic Dermatitis" (1 trials), "Atopic Dermatitis (AD)" (1 trials), "Eczema Herpeticum" (1 trials), "Multi-food Allergy" (1 trials) and "Non-atopic Healthy Controls" (1 trials). Many other conditions were trialed in "National Jewish Health: Division of Pediatric Allergy and Clinical Immunology" in a lesser frequency.

Most popular intervention types in "National Jewish Health: Division of Pediatric Allergy and Clinical Immunology" are "Drug" (2 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Double-Blind Placebo-Controlled Food Challenge Based Treatment" (1 trials), "Dupilumab" (1 trials), "Multi-Allergen Oral Immunotherapy" (1 trials), "Omalizumab" (1 trials) and "Placebo for Multi-Allergen Oral Immunotherapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "National Jewish Health: Division of Pediatric Allergy and Clinical Immunology" are 4 trials for "All" genders.

Currently, there are NaN active trials in "National Jewish Health: Division of Pediatric Allergy and Clinical Immunology". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in National Jewish Health: Division of Pediatric Allergy and Clinical Immunology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in National Jewish Health: Division of Pediatric Allergy and Clinical Immunology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".